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Abstract. Lactating bonnet monkeys were used as a model to understand the mechanism of
ovarian quiescence during lactation. The ovary of the bonnet monkey in the 3rd month of
lactation responds well to exogenous pregnant mare serum gonadotropin stimulation with
serum estrogen values reaching maximal levels by day 3 of the gonadotropin injection. The
adminstration of ovine prolactin to such monkeys significantly inhibited the ovarian
responsiveness to exogenous gonadotropin. The responsiveness of the pituitary of the
lactating monkey (in the 3rd month of lactation) to luteinizing hormone releasing hormone
injection was suppressed and supplementation with exogenous prolactin further accentuating
this effect. The relative ability of chlorpromazine given intravenously/intramuscular-
ly/intranasally to enhance endogenous prolactin levels was assessed. During the first 5 months
of lactation when the basal prolactin levels were high, the luteinizing hormone levels were low.
As the suckling stimulus reduces and prolactin levels fall, luteinizing hormone levels increase,
the first post-parturient mensus occurring by 218 ± 4 days. This event was postponed by 3
months on increasing endogenous prolactin levels by administering chlorpromazine
(250 µg/day by intranasal mode) over a 5 day period every month starting from the 3rd month
of lactation.
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Introduction 
 
The mechanism whereby ovarian quiescence occurs during lactation is still not well
understood. The data largely obtained using the lactating rat as the experimental model
suggested that high levels of prolactin seen during lactation must be affecting the
normal functioning of the hypothalamo-pituitary axis (Muralidhar et al., 1977;
Maneckjee et al., 1976) as well as the responsiveness of the target tissue to
gonadotropins (Maneckjee and Moudgal, 1975; Maneckjee et al., 1977) by mechanisms
presently unknown. In the lactating rat the level of circulating prolactin could easily be
regulated by reducing or increasing the number of pups suckling indicating that the
 
 
* To  whom  reprint  requests  should  be  addressed.
Abbreviations used: LH, Luteinizing hormone; RIA, radioimmunoassay; s.c., subcutaneous; PMSG,
pregnant mare serum gonadotropin; IU, international units; i.m. intramuscular; LHRH, luteinizing hormone
releasing hormone; i.v., intravenously.
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intensity of suckling is directly correlated to circulating prolactin levels (Amenomori et
al., 1970; Trekle et al., 1972). Since this was not feasible in the lactating monkey,
recourse to the use of drugs like chlorpromazine which increased prolactin level has
been taken. The results presented herein essentially reviews our earlier work in the
lactating monkey and describes some of the newer information obtained on the effect of
increasing endogenous circulating prolactin level by drug therapy on ovarian function
in  the  lactating  monkey.
 
Materials  and  methods
 
Information on the essential reproductive cycle of the female bonnet monkey (Murty et
al., 1980) and their husbandry (Srinath, 1980) in the laboratory has been provided
earlier. In the bonnet monkey lactation normally lasts for 6 months as by this time the
baby is beginning to partake more and more of the solid food provided to the mother.
Lactating mothers are individually caged with their babies and the babies are separated
from the mothers only after the occurrance of the first post-parturient menses and this
occurs by 218 ± 4 days of lactation.
The estrogen and luteinizing hormone (LH) levels in the serum were monitored using
radioimmunoassay (RIA) methods standardized in this laboratory earlier by Mukku
and Moudgal (1975) and Ramasharma et al. (1978) respectively. The serum prolactin
levels were measured using the human prolactin RIA kit kindly provided by NIAMDD,
Bethesda,  Maryland,  USA.
The drug chlorpromazine was administered using the nasal spray mode in 10 s sprays
up each nostril of unanesthetized monkeys according to the procedure described by
Anand Kumar et al. (1977). The drug was given dissolved in a vehicle made up of
ethanol:  propylene  glycol:  water  (3:3:4).  Control  monkeys,  received  vehicle  only. 
 
Results and  dissussion
 
Ovarian responsiveness of lactating bonnet monkeys to exogenous gonadotropins
 
Lactating bonnet monkeys caged individually with their babies were given in the 3rd
month of lactation a daily subcutaneous (s.c.) injection of pregnant mare serum
gonadotropin (PMSG) in saline according to the following schedule: day 1–250
international units (IU); day 2–200 IU; day 3–150 IU; days 4 and 5–100 IU and days 6, 7
and 8–75 IU. The choice of monkeys in the 3rd month of lactation was based on our
earlier laparoscopic examination of such monkeys which indicated that the ovaries at
this time do not contain discernible developing follicles or corpus luteum. While one
group of 4 monkeys received the above regimen a second group of 4 monkeys received
in addition to PMSG a daily intramuscular (i.m.) injection of 2 mg of ovine prolactin
(NIH preparation) given 1 h earlier to PMSG. Blood samples were removed from
femoral venepuncture at time 0 and 24 h after each PMSG injection for estrogen
estimation in serum by appropriate RIA standardized in this laboratory (Mukku and
Moudgal,  1975).
The results (figure 1) indicate that the ovary of the monkey even during the active
 
Lactational  amennorrhea  in monkey 97
 
 
Figure 1. Ovarian responsiveness of monkeys in the 3rd month of lactation to PMSG
injection and the effect of prolactin on this. Details of the PMSG and prolactin dose given are
provided  in  the  text.  n  of  each group  was  4. (●),  No prolactin;  (○), with prolactin.
*Significantly different from the corresponding controls Ρ < 0·01 (after Maneckjee et al.,
1977).
 
phase of lactation was able to respond to exogenous gonadotropin by producing
significant elevations in estrogen levels. Interestingly, this ability of PMSG to evoke a
response was markedly reduced by administering lactating monkeys an additional dose
of 2 mg of ovine prolactin/day. The inhibition in response was significant from day 4 of
PMSG treatment (P < 0·0l). The mechanism by which prolactin inhibited ovarian
response  is  presently  unclear.
 
Responsiveness of the pituitary of lactating monkeys to exogenous luteimizing hormone
releasing hormone
 
We had earlier observed (Maneckjee et al., 1976) that the efficacy of exogenous
luteinizing hormone releasing hormone (LHRH) (l00 µg AY-24, 031-4 gifted by Dr. F.
Labrie) given intraveneously (i.v.) dissolved in 1 ml of 0·9 % NaCl, to stimulate secretion
of LH was significantly effected if the lactating monkey was actively suckling the baby.
All monkeys used in this experiment were in the 2nd month of lactation. Unlike in the
actively suckling group where the baby was left with the mother, in the control group
the baby was removed from the mother for 24 h before injecting LHRH. Thus in the
control group (figure 2B) the LH levels in serum increased significantly by 10 min but
returned to basal values by 20 min. In contrast, in addition to the actively suckling
group (figure 2A) having a lowered basal LH levels (control: 0·95 ± ·0·7 ng hLH/ml vs
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Figure 2. Effect of prolactin on pituitary response to LHRH during lactation in the
presence (A) and absence of suckling stimulus (B). Ρ values were calculated for values at any
given time between the treated and untreated groups. All values > 0.05 were considered to be
not significant.
* P < 0·02 (○),  No  Prolactin; (●), plus  prolactin.
 
actively suckling group: 0·6 ± 0.12 ng hLH/ml Ρ < 0·001), they take a longer time to
show maximal increase (20 min) and the levels were maintained at this level for 40 min
(figure 2A). The difference between the control lactating vs actively suckling lactating
group was more evident when 5 mg of ovine prolactin (NIH PS5) dissolved in 0·5 ml of
0·9% NaCl was injected i.v. 1 h prior to LHRH injection. Prolactin injection
significantly inhibited (P < 0·05) the responsiveness of the actively suckling lactating
monkey to exogenous LHRH (figure 2A). In an independent study when responsive-
ness of actively lactating monkeys on different days of lactation (on day 15, 45, 75, 105
and 145 days of lactation) to 100 µg of LHRH was compared it was observed that
between days 45 to 105 the increase in LH was only minimal (increase by 20–30 %). In
contrast on day 145 of lactation circulating LH levels could be increased by 400%
within 20 min of injecting 100 µg LHRH. These studies lead us to the conclusion that in
addition to the neurogenic stimulus of suckling the circulating level of prolactin has an
influence  on  the  overall  responsiveness  of  the pituitary  to  exogenous  LHRH.
 
Effect of increasing endogenous prolactin levels on circulating LH levels in lactating
monkeys
 
Since some of the above conclusions were based on the ability of exogenous prolactin to
influence pituitary as well as gonadal responses it was felt worthwhile to determine: (a) a
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suitable method of increasing endogenous circulating levels of prolactin by drug
treatment and (b) its effect on circulating LH levels in monkeys at different months of
lactation.
The relative ability of 1 mg of chlorpromazine injected by i.v. and i.m. route to
increase endogenous prolactin levels is shown in figure 3A. Prolactin was measured by
RIA in serum samples obtained at different periods following the drug administration.
To achieve a response equivalent to the i.v. injection 5 times the dose (5 mg) had to be
given by i.m. (figure 3B). Interestingly administration of the drug by intranasal route
using a method standardized by Anand Kumar et al. (1977) showed that the drug
dosage could be markedly reduced (× 4 less than the i.v. and × 20 less than the i.m.
dose) without a loss in its ability to significantly increase prolactin levels (figure 4). The
ability of the drug, when administered by intranasal route to modulate LH levels also
was checked by administering ovariectomized monkeys 250 and 500 µg of chlorpro-
mazine. It is evident from figure 5 that the drug had no effect on the high LH levels seen
in  the  ovariectomized  monkeys.
 
 
Figure 3. Establishing the dose and route of administration of chlorpromazine to increase
serum  prolactin levels.
A. Effect of injecting chlorpromazine (1 mg/monkey) by i.m. and i.v. routes on serum
prolactin  levels  (n  of  each group 3).
B. Effect of injecting different doses of chlorpromazine by i.m. route on serum prolactin levels
of  monkeys.
 
Assuming that monkeys during active lactation phase also would be going through
‘silent abberant cycles’ of approximately 28 days duration, groups of lactating monkeys
(n per group was 3) in the 3rd and 4th and 5th month of lactation were administered
daily at the same hour between 10–14th day of cycle, 250 µg of chlorpromazine by
nasal spray. The control group received instead of the drug only the vehicle. The day of
parturition was reckoned as day 1 of the first cycle and each cycle thereon was assumed
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Figure 4. Effect of intranasal administration of chlorpromazine on serum prolactin levels.
The drug was given in 10 sec sprays up each nostril to unanesthetized monkeys according to the
procedure of Anand Kumar et al., (1977). n of each group was 3. The control monkeys received
the vehicle (ethanol: propyleneglycol: water, 3:3:4) only. The efficiency of the nasal spray
device was 1·3%.
 
 
Figure 5. Relative effect of chlorpromazine nasal spray on prolactin and LH levels of
ovariectomized monkeys-establishment of specificity of effect. Values are mean of 2
monkeys. Other procedures are similar to that described in figure 4.
 
to be of 28 days duration. Blood samples removed on each of the 5 days before nasal
spray were assayed for prolactin and LH using appropriate RIAs standardized in the
laboratory (Ramasharma et al., 1978). The results presented in figure 6 are mean of 5
samples taken from 3 monkeys each month in the control and treated group. It is
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Figure 6. Effect of administering chlorpromazine by nasal spray 250 µg/day/monkey
between days 10–14 of each of 28 day 'silent cycles' (see text for explanation) starting from the
3rd month of lactation on serum prolactin and LH levels. The values reported are mean of 5
samples collected each day before the spray from 3 monkeys in each group. (●), Control; (○),
drug treated. 
* Significantly  different  from  appropriate  controls  Ρ  <  0·05.
 
evident that in the control group prolactin levels decreased markedly by the 5th month
of lactation and by this time LH levels of the controls also showed a marked elevation.
In the drug treated group, however, the decrease in prolactin by significant amounts
occurred only by the 8th month and this coincided with the occurrence in LH levels in
that month in surge amounts. It should be noted that by this time despite the drug
induced high prolactin levels, due to reduced suckling (as the baby starts sharing more
and  more  of  the  solid  food  of  the  mother)  the  LH  levels  tend  to increase.
 
Effect of increasing serum prolactin levels on the return to cyclicity of lactating bonnet
monkeys
 
It is evident from the results presented in table 1 that increasing serum prolactin levels
either by exogenous ovine prolactin injection or by drug treatment leads to a significant
postponement (by 3 months) in the onset of first postparturient menses. It is apparently
not possible to postpone the occurrence of menses any further due to marked reduction
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Table 1. Effect of increasing serum prolactin levels on the return to cyclicity of
lactating bonnet monkeys. 
 
 
Vehicle or drug was given by injection or nasal spray on days 10–14 of each month
(of 28 day duration) beginning the 3rd month of lactation. Numbers in parenthesis
indicate N.
* Significantly  different from  the  controls Ρ <  0·001.
 
in the suckling stimulus. Administration of as low as 250 µg of chlorpromazine per day
for 5 days per cycle by nasal spray seems to be adequate to achieve the desired goal.
 
Conclusion 
 
It appears from the foregoing that while the ovary of the lactating bonnet monkey is 
capable of responding to exogenous gonadotropin stimulus, its responsiveness in terms
of estrogen production can be severely curtailed by exogenous prolactin treatment. A
similar observation was made earlier using the lactating rat as a model system
(Maneckjee et al., 1977). The mechanism by which excess prolactin inhibits the ability of
the ovary to produce estrogen in response to exogenous gonadotropin is yet to be
unraveled. Prolactin also appeared to influence the sensitivity of the pituitary to
exogenous LHRH. The lactating state is exemplified by the presence of two types of
stimuli, the neurogenic stimulus of suckling and high prolactin levels. It appears that
high prolactin levels in itself, in the absence of ‘suckling stimulus’ is unable to influence
pituitary responsiveness to exogenous LHRH. This perhaps is the reason why
chlorpromazine treatment every month starting from the 3rd month of lactation was
not able to postpone the onset of first post-parturient menses indefinitely, the day of 1st
menses could be postponed by 3 months only (from 218 to 312 days). Endogenous
prolactin level has been increased in the present series of experiments by giving the
drug chlorpromazine. Interestingly the dosage of the drug could be markedly reduced
(by × 20) if it was delivered in the nasal spray mode. At this low level (250 µg), the drug
did not induce sleep in the receipient monkeys. Whether this type of drug therapy can
be used in lactating women to extend the state of lactational amennorhea is perhaps
worth investigating. It is possible that other drugs effecting central nervous system can
also be delivered by the intranasal mode. We have observed for instance, that the
effective dose of ergobromocryptin, a drug reducing prolactin levels can be significantly
reduced  by  giving  it  by  the  intranasal  mode.
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